These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 9636566

  • 1. Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus).
    Van Buren D, Payne J, Geevarghese S, MacDonell R, Chapman W, Wright JK, Helderman JH, Richie R, Pinson CW.
    Transplant Proc; 1998 Jun; 30(4):1401-2. PubMed ID: 9636566
    [Abstract] [Full Text] [Related]

  • 2. Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients.
    Van Buren D, Payne J, Geevarghese S, MacDonell R, Chapman W, Wright JK, Helderman JH, Richie R, Pinson CW.
    Transplant Proc; 1998 Aug; 30(5):1830-2. PubMed ID: 9723299
    [Abstract] [Full Text] [Related]

  • 3. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 4. Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients.
    Rabkin JM, Rosen HR, Corless CL, Olyaei AJ.
    Transplant Proc; 2002 Aug; 34(5):1557-8. PubMed ID: 12176483
    [No Abstract] [Full Text] [Related]

  • 5. Neoral is superior to FK 506 in liver transplantation.
    Levy GA.
    Transplant Proc; 1998 Aug; 30(5):1812-5. PubMed ID: 9723293
    [No Abstract] [Full Text] [Related]

  • 6. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
    Johnson C, Ahsan N, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, van Veldhuisen P, Salm K, Tolzman D, Fitzsimmons WE.
    Transplantation; 2000 Mar 15; 69(5):834-41. PubMed ID: 10755536
    [Abstract] [Full Text] [Related]

  • 7. Experience with neoral cyclosporine through the oral route in liver transplantation.
    Bilbao I, Lazaro JL, Pou L, Charco R, Hildalgo E, Murio E, Margarit C.
    Transplant Proc; 1998 Jun 15; 30(4):1432-4. PubMed ID: 9636580
    [No Abstract] [Full Text] [Related]

  • 8. Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation.
    Levy G, Villamil F, Samuel D, Sanjuan F, Grazi GL, Wu Y, Marotta P, Boillot O, Muehlbacher F, Klintmalm G, LIS2T Study Group.
    Transplantation; 2004 Jun 15; 77(11):1632-8. PubMed ID: 15201658
    [Abstract] [Full Text] [Related]

  • 9. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct 15; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 10. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
    Bilbao I, Pou L, Allende E, Lázaro JL, Charco R, Hidalgo E, Margarit C.
    Transplant Proc; 2001 May 15; 33(3):2124-6. PubMed ID: 11377472
    [No Abstract] [Full Text] [Related]

  • 11. Conversion from tacrolimus to Neoral in liver and kidney transplant recipients.
    Ott R, Bussenius-Kammerer M, Scholz D, Neuhaus R, Tolba RH, Fricke L, Müller V.
    Transplant Proc; 2001 May 15; 33(7-8):3166-8. PubMed ID: 11750359
    [No Abstract] [Full Text] [Related]

  • 12. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
    Yu L, Wang Y, Fu SJ, Cheng XJ.
    Transplant Proc; 2000 Nov 15; 32(7):1709-10. PubMed ID: 11119902
    [No Abstract] [Full Text] [Related]

  • 13. Single-center, open, prospective, randomized pilot study comparing cyclosporine versus tacrolimus in simultaneous pancreas-kidney transplantation.
    Boggi U, Vistoli F, Del Chiaro M, Croce C, Morelli L, Coletti L, Signori S, Giannarelli R, Marchetti P, Del Prato S, Rizzo G, Mosca F.
    Transplant Proc; 2004 May 15; 36(4):1064-6. PubMed ID: 15194369
    [Abstract] [Full Text] [Related]

  • 14. Weaning of immunosuppression in liver transplant recipients.
    Mazariegos GV, Reyes J, Marino IR, Demetris AJ, Flynn B, Irish W, McMichael J, Fung JJ, Starzl TE.
    Transplantation; 1997 Jan 27; 63(2):243-9. PubMed ID: 9020325
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation.
    Klupp J, Glanemann M, Bechstein WO, Platz KP, Langrehr JM, Keck H, Settmacher U, Radtke C, Neuhaus R, Neuhaus P.
    Transplant Proc; 1999 Jan 27; 31(1-2):1113-4. PubMed ID: 10083497
    [No Abstract] [Full Text] [Related]

  • 16. Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group.
    Wiesner RH.
    Transplant Proc; 1998 Jun 27; 30(4):1399-400. PubMed ID: 9636565
    [No Abstract] [Full Text] [Related]

  • 17. Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial.
    Langrehr JM, Klupp J, Junge G, Jonas S, Neuhaus R, Bechstein WO, Neuhaus P.
    Transplant Proc; 2001 May 27; 33(3):2330-1. PubMed ID: 11377549
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A prospective study comparing safety and efficacy of mycophenolate mofetil versus azathioprine in primary liver transplant recipients.
    Fischer L, Sterneck M, Gahlemann CG, Malago M, Rogiers X, Broelsch CE.
    Transplant Proc; 2000 Nov 27; 32(7):2125-7. PubMed ID: 11120098
    [No Abstract] [Full Text] [Related]

  • 20. Two-year outcome in renal allograft recipients comparing neoral-led with tacrolimus-led therapy.
    Wayman MR, Oniscu GC, Forsythe JL, Whitworth CE.
    Transplant Proc; 2002 Aug 27; 34(5):1663-5. PubMed ID: 12176526
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.